PharosAI is excited to announce a major funding milestone with a raise of £44,000,000, marking a bold new chapter in the integration of cutting-edge AI technology into healthcare. This significant investment underscores our commitment to transforming cancer clinical workflows and R&D processes by embedding powerful AI capabilities directly into diagnostic and treatment decision support. Imagine a future where the latest in artificial intelligence drives faster, more precise discoveries and clinical insights—this is the vision that PharosAI is turning into reality. By leveraging this new capital, our aim is to build unique, high-quality, and richly detailed patient datasets that capture the full breadth of clinical experiences, thus paving the way for more individualized and efficient care. Our platform is developed in strong partnership with leading institutions such as King’s College London, Guy’s and St Thomas Foundation Trusts, Barts Cancer Institute, and Barts Health Trust, in addition to collaborations with NHS England, UK Biobank, and the Royal College of Pathologists, among others. This network of expertise and excellence fuels our mission to navigate the path toward AI-assisted healthcare within the NHS, ensuring that the benefits of advanced technology reach all patients. Moreover, a key aspect of this funding is to empower the workforce by providing them with the knowledge and skills required to adopt an AI-enabled future. Ultimately, PharosAI is dedicated to accelerating the UK's vision of delivering the right treatment at the right time, breaking down socioeconomic barriers and setting a new standard in precision medicine.
PharosAI Raises $44M to Accelerate AI-Enabled Healthcare Revolution in the NHS
Recently funded · £44.0MHealthcare
Get the full PharosAI company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
